Journal
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 97, Issue 17, Pages 9498-9503Publisher
NATL ACAD SCIENCES
DOI: 10.1073/pnas.150006697
Keywords
-
Categories
Funding
- NCI NIH HHS [CA47399, R01 CA047399] Funding Source: Medline
Ask authors/readers for more resources
c-Myc plays a vital role in cell-cycle progression, Deregulated expression of c-Myc can overcome cell-cycle arrest in order to promote cellular proliferation. Transforming growth factor beta (TCF beta) treatment of immortalized human keratinocyte cells inhibits cell-cycle progression and is characterized by dawn-regulation of c-Myc followed by up-regulation of p21(CIP1). A direct role of c-Myc in this pathway was demonstrated by the observation that ectopic expression of c-Myc overcame the cell-cycle block induced by TGF beta treatment The induction of p21(CIP1) transcription by TGF beta was blocked in human keratinocyte cells stably expressing E-Myc, Furthermore, overexpression of c-Myc in NIH 3T3 cells repressed the basal levels of p21(CIP1) mRNA. Repression of p21(CIP1) transcription by c-Myc occurred at the promoter level in a region near the start site of transcriptional initiation and was independent of histone deacetylase activity. These data suggest that the down-regulation of c-Myc after TGF beta signaling is important for subsequent regulation of p21(CIP1) and cell-cycle inhibition. Thus, repression of the cell-cycle inhibitory gene p21(CIP1) plays a role in c-Myc-dependent cell-cycle progression.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available